Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Liabilities ₹1,026 Cr₹880 Cr₹793 Cr₹739 Cr₹157 Cr

What is the latest Total Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Liabilities ratio of NATH BIOGENES (INDIA) is ₹1,026 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹1,026 Cr
Mar2024₹880 Cr
Mar2023₹793 Cr
Mar2022₹739 Cr
Mar2013₹157 Cr

How is Total Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Liabilities % Change
Mar2025 ₹1,026 Cr
16.58
Mar2024 ₹880 Cr
11.03
Mar2023 ₹793 Cr
7.21
Mar2022 ₹739 Cr
369.87
Mar2013 ₹157 Cr -

Compare Total Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹305.2 Cr -2.5% -4.7% -7.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,777.9 Cr 5.3% -1.3% -20.7% Stock Analytics
KAVERI SEED COMPANY ₹5,157.5 Cr -6.2% -5.6% 28.1% Stock Analytics
VENKYS (INDIA) ₹1,907.8 Cr 0.4% -6.6% -22% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,197.4 Cr -2.7% -6.2% -27.6% Stock Analytics
INDO US BIOTECH ₹248.8 Cr -4.7% 0.9% -48.7% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.5%

-4.7%

-7.6%

SENSEX

0.9%

2.1%

8.3%


You may also like the below Video Courses